Delivery Order SPE2DB20D3104-SPE2DB24FV8H4
- Not listed
- This federal contract award, valued at $1,059.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humalog 100 Unit/mL KwikPen 3mL, a diabetes medication, with a performance period extending through April 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,114.44, is for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a diabetes medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,649.30, is a delivery order for the supply of Humalog 100 Unit/mL Kwikpen 3mL, a diabetes medication. The contract has an ultimate completion date of January 15, 2025 and utilizes a firm fixed-price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a firm fixed price of $1,497.60 and a period of performance through January 10, 2024. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.41 Firm Fixed Price Delivery Order contract is for the supply of Humalog 100 Unit/mL Kwikpen 3mL, a diabetes medication. The contract has an ultimate completion date of May 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $1,707.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humalog 100 unit/mL Kwikpen 3mL, a prescription medication used to treat diabetes. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 unit/mL Kwikpen 3mL medication. The contract has a total ceiling value of $1,103.52 and is a fixed-price delivery order with a completion date of June 21, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $1,365.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a medication used to manage diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of November 4, 2024. This award is not associated with a set-aside program, indicating...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,957.44 firm-fixed-price award is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a diabetes medication. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,589.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humalog 100 unit/mL Kwikpen 3mL, a diabetes medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB24FV8H4Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Humalog 100 Unit/mL KwikPen 3mL, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,713.48 and a performance period through July 23, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/22/24 |